Atlas Trials

Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

Clinical trial NCT03785405 · COMPLETED

Trial details

NCT number
NCT03785405
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure
Start date
2019-05-02
Primary completion
2023-12-29
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.